Orexo AB (publ) (ORXOY) Discusses Divestment of US Rights to Zubsolv and Transition Agreement with Dexcel Pharma Transcript [Seeking Alpha]
OREXO AB SP/ADR (ORXOY)
NASDAQ:AMEX Investor Relations:
orexo.com/en/investors
Company Research
Source: Seeking Alpha
Company Participants Nikolaj Sørensen - President & CEO Frederik Jarrsten - Executive VP & CFO Conference Call Participants Klas Palin - DNB Carnegie Commissioned research Samir Devani - Rx Securities Limited, Research Division Presentation Operator Welcome to the conference call. [Operator Instructions] Now I will hand the conference over to the speakers. Please go ahead. Nikolaj Sørensen President & CEO Thank you very much, and welcome to this call updating you about the transaction that we completed yesterday evening. And first, I just want to extend my apologies for disturbing you here on the 23rd of December, where most of you probably would like to go Christmas shopping or starting the vacation. But for us, this is a major step and something we've been working intensively on throughout the autumn and that we're now able to close this transaction just before Christmas is very welcome, and we think is the right thing for Orexo to do in our current state. S
Show less
Read more
Impact Snapshot
Event Time:
ORXOY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORXOY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORXOY alerts
High impacting OREXO AB SP/ADR news events
Weekly update
A roundup of the hottest topics